相关实验视频
Updated: May 21, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.4K
H2GnnDTI:用于药物向相互作用预测的层次异质图神经网络
Yueying Jing1, Dongxue Zhang1, Limin Li1
1School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.
Bioinformatics (Oxford, England)
|March 17, 2025
概括
我们开发了H2GnnDTI,这是一种新的图形学习模型,利用层次信息来预测药物向相互作用 (DTI). 这种方法显著改进了现有的深度学习方法,用于药物发现和重新使用.
科学领域:
- 计算生物学是一种计算生物学.
- 生物信息学是一种生物信息学.
- 机器学习 机器学习
背景情况:
- 准确识别药物向相互作用 (DTI) 对于药物发现和重新使用至关重要.
- 用于DTI识别的实验方法是昂贵和耗时的,需要高效的计算方法.
- 现有的计算方法往往无法充分利用DTI固有的复杂层次结构.
研究的目的:
- 介绍H2GnnDTI,这是一款用于预测DTI的新型两级层次层次图形学习模型.
- 在低层和高层视图中有效地整合药物和蛋白质的结构和化学信息.
- 通过利用层次数据,提高DTI预测的准确性和全面性.
主要方法:
- 采用了一个双层层次的分层异质图形学习框架 (H2GnnDTI).
- 低级图形神经网络 (GNN) 从分子/氨基酸水平图表中捕获药物和蛋白质的特定特征.
- 一个高级图形编码器集成了低级GNN和DTI图形的特征,用于共识表示学习.
主要成果:
- 通过双层GNN方法,H2GnnDTI成功地整合了药物和蛋白质结构.
- 该模型有效地捕获和合并了使用高级图形编码器与融合模块的交互功能.
- 广泛的实验表明,H2GnnDTI在基准数据集上始终超过了最先进的深度学习方法.
结论:
- H2GnnDTI提供了一种强大的新计算工具,用于预测药物向相互作用.
- 层次图形学习方法有效地利用复杂的数据结构来改进DTI预测.
- 该模型的卓越性能为加速药物发现和重新定位努力提供了显著的潜力.
相关概念视频
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Drug-Receptor Interaction: Antagonist
2.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.6K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Agonism and Antagonism: Quantification
292
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
292

